AU714642B2 - G-protein receptor HTNAD29 - Google Patents
G-protein receptor HTNAD29 Download PDFInfo
- Publication number
- AU714642B2 AU714642B2 AU28204/95A AU2820495A AU714642B2 AU 714642 B2 AU714642 B2 AU 714642B2 AU 28204/95 A AU28204/95 A AU 28204/95A AU 2820495 A AU2820495 A AU 2820495A AU 714642 B2 AU714642 B2 AU 714642B2
- Authority
- AU
- Australia
- Prior art keywords
- polypeptide
- polynucleotide
- receptor
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU26430/00A AU760468B2 (en) | 1995-06-06 | 2000-04-06 | G-protein receptor HTNAD29 |
AU2003235001A AU2003235001A1 (en) | 1995-06-06 | 2003-08-14 | G-Protein Receptor HTNAD29 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007288 WO1996039442A1 (fr) | 1995-06-06 | 1995-06-06 | Htnad29 recepteurs de proteines g |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26430/00A Division AU760468B2 (en) | 1995-06-06 | 2000-04-06 | G-protein receptor HTNAD29 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2820495A AU2820495A (en) | 1996-12-24 |
AU714642B2 true AU714642B2 (en) | 2000-01-06 |
Family
ID=22249278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28204/95A Ceased AU714642B2 (en) | 1995-06-06 | 1995-06-06 | G-protein receptor HTNAD29 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0832126A4 (fr) |
JP (1) | JPH11506341A (fr) |
KR (1) | KR19990022531A (fr) |
CN (1) | CN1147505C (fr) |
AU (1) | AU714642B2 (fr) |
CA (1) | CA2221706A1 (fr) |
WO (1) | WO1996039442A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221627B1 (en) | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US6733990B1 (en) | 1999-08-03 | 2004-05-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family |
EP2264068A1 (fr) * | 1998-10-13 | 2010-12-22 | Arena Pharmaceuticals, Inc. | Récepteurs non-endogènes de la protéine G humaine ayant une activité constitutive |
US6919176B2 (en) | 2001-05-07 | 2005-07-19 | Amgen Inc. | Polypeptides and nucleic acids associated with cancer |
AU2003206749A1 (en) * | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
MXPA05013721A (es) | 2003-06-20 | 2006-03-08 | Novartis Ag | Receptores acoplados con proteina-g de deteccion de protones, y secuencias de adn de los mismos. |
WO2008101354A1 (fr) * | 2007-02-22 | 2008-08-28 | Merck Frosst Canada Ltd | Gpr65 utilisé comme cible thérapeutique dans une inflammation allergique des voies respiratoires |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262529A (en) * | 1990-01-24 | 1993-11-16 | President And Fellows Of Harvard College | Diagnosis of hereditary retinal degenerative diseases |
US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
JPH06511386A (ja) * | 1991-10-01 | 1994-12-22 | アメリカ合衆国 | リガンドおよびリガンドのアンタゴニストを同定する方法 |
US5508384A (en) * | 1992-09-10 | 1996-04-16 | New York University | Polypeptide derived from a popamine receptor, and compositions and methods thereof |
US6066322A (en) * | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
-
1995
- 1995-06-06 CA CA002221706A patent/CA2221706A1/fr not_active Abandoned
- 1995-06-06 KR KR1019970709012A patent/KR19990022531A/ko not_active Application Discontinuation
- 1995-06-06 JP JP9500379A patent/JPH11506341A/ja active Pending
- 1995-06-06 EP EP95923763A patent/EP0832126A4/fr not_active Withdrawn
- 1995-06-06 AU AU28204/95A patent/AU714642B2/en not_active Ceased
- 1995-06-06 WO PCT/US1995/007288 patent/WO1996039442A1/fr not_active Application Discontinuation
- 1995-06-06 CN CNB951979256A patent/CN1147505C/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
PRODEED. NAT. ACAD. SCI., VOL 87 (APRIL 1990) ROSS ET AL. * |
SCIENCE, VOL 244 (5 MAY 1989) LIBERT ET AL. * |
Also Published As
Publication number | Publication date |
---|---|
KR19990022531A (ko) | 1999-03-25 |
EP0832126A4 (fr) | 2000-01-12 |
CA2221706A1 (fr) | 1996-12-12 |
JPH11506341A (ja) | 1999-06-08 |
AU2820495A (en) | 1996-12-24 |
EP0832126A1 (fr) | 1998-04-01 |
CN1147505C (zh) | 2004-04-28 |
CN1193980A (zh) | 1998-09-23 |
WO1996039442A1 (fr) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6511826B2 (en) | Polynucleotides encoding human G-protein chemokine receptor (CCR5) HDGNR10 | |
US20010000241A1 (en) | Antibodies to human G-protein chemokine receptor HDGNR10 (CCR5 receptor) | |
US20080241124A1 (en) | Human G-Protein Chemokine Receptor (CCR5) HDGNR10 | |
US5776729A (en) | Human G-protein receptor HGBER32 | |
US20030044898A1 (en) | Human G-protein coupled receptors | |
US20050214281A1 (en) | G-protein coupled receptor | |
US20050266527A1 (en) | Human G-protein receptor HIBEF51 | |
AU714642B2 (en) | G-protein receptor HTNAD29 | |
US20020106740A1 (en) | Human G-protein receptor HPRAJ70 | |
US6338951B1 (en) | G-protein parathyroid hormone receptor HLTDG74 | |
US20110112177A1 (en) | Human G-Protein Coupled Receptor (HETGQ23) | |
EP0955808A1 (fr) | Recepteur couple de la proteine g humaine | |
US20020106741A1 (en) | G protein receptor HTNAD29 | |
US20080312178A1 (en) | Human G-Protein Receptor HGBER32 | |
CA2220978A1 (fr) | Recepteur couple de proteines g humaines (hetgq23) | |
AU760468B2 (en) | G-protein receptor HTNAD29 | |
AU716023B2 (en) | Human G-protein coupled receptor (HETGQ23) | |
AU763827B2 (en) | Human G-protein coupled receptor (HETGQ23) | |
US20020086362A1 (en) | Human amine receptor | |
WO1996039441A1 (fr) | Hibef51, recepteur de proteines g humaines | |
US20020106734A1 (en) | Adrenergic receptor | |
US20060014243A1 (en) | Human G-protein chemokine receptor HSATU68 | |
EP0832123A1 (fr) | Recepteur hltdg74 de l'hormone parathyroidienne (hpt) couple a la proteine g | |
AU2003235001A1 (en) | G-Protein Receptor HTNAD29 | |
AU3535300A (en) | Human G-protein coupled receptor (HETGQ23) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |